Page last updated: 2024-12-11

3,3'-diethylthiatricarbocyanine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,3'-diethylthiatricarbocyanine: RN given refers to 3H-labeled parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6370500
CHEMBL ID1179519
SCHEMBL ID10110715
MeSH IDM0085659

Synonyms (14)

Synonym
3-ethyl-2-[(1e,3e,5e,7z)-7-(3-ethyl-1,3-benzothiazol-2(3h)-ylidene)hepta-1,3,5-trien-1-yl]-1,3-benzothiazol-3-ium
STK396359
3,3'-diethylthiatricarbocyanine
benzothiazolium, 3-ethyl-2-(7-(3-ethyl-2(3h)-benzothiazolylidene)-1,3,5-heptatrienyl)-,
(2z)-3-ethyl-2-[(2e,4e,6e)-7-(3-ethyl-1,3-benzothiazol-3-ium-2-yl)hepta-2,4,6-trienylidene]-1,3-benzothiazole
CHEMBL1179519
23178-68-9
(2e)-3-ethyl-2-[(2e,4e,6e)-7-(3-ethyl-1,3-benzothiazol-3-ium-2-yl)hepta-2,4,6-trienylidene]-1,3-benzothiazole;iodide
bdbm95089
cid_9937256
SCHEMBL10110715
bdbm51921
cid_5702699
DTXSID30177754
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (38.46)18.7374
1990's0 (0.00)18.2507
2000's2 (15.38)29.6817
2010's5 (38.46)24.3611
2020's1 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.80 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index28.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]